Jon Congleton
Chief Executive Officer at MINERALYS THERAPEUTICS, INC.
Net worth: 16 M $ as of 29/04/2024
Jon Congleton active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Director/Board Member | - | - |
| Chief Executive Officer | 31/10/2020 | - | |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Private Equity Investor | - | - |
Career history of Jon Congleton
Former positions of Jon Congleton
| Companies | Position | Start | End |
|---|---|---|---|
| IPI LEGACY LIQUIDATION CO | Director/Board Member | - | 04/05/2020 |
| Chief Executive Officer | 02/10/2017 | 04/05/2020 | |
| President | 02/10/2017 | 04/05/2020 | |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | Director/Board Member | 21/12/2014 | 14/01/2017 |
| Chief Executive Officer | 21/12/2014 | 14/01/2017 | |
| President | 21/12/2014 | 14/01/2017 | |
| ALPINE IMMUNE SCIENCES, INC. | Chief Executive Officer | - | 31/12/2016 |
| President | - | 31/12/2016 | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Sales & Marketing | - | - |
Teva Neuroscience, Inc.
 Teva Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Teva Neuroscience, Inc. developed and marketed drugs for neurological disorders. The company's product COPAXONE was used to reduce relapses caused by relapsing-remitting multiple sclerosis. It also offered treatment for Parkinson's disease. Teva Neuroscience was founded in 1997 and was located in Kansas City, MO | Corporate Officer/Principal | 18/11/2010 | - |
Training of Jon Congleton
| Kansas State University | Undergraduate Degree |
Statistics
International
| United States | 7 |
| Israel | 2 |
| Japan | 2 |
Operational
| Chief Executive Officer | 4 |
| Director/Board Member | 3 |
| President | 3 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| IPI LEGACY LIQUIDATION CO | Health Technology |
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Teva Neuroscience, Inc.
Teva Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Teva Neuroscience, Inc. developed and marketed drugs for neurological disorders. The company's product COPAXONE was used to reduce relapses caused by relapsing-remitting multiple sclerosis. It also offered treatment for Parkinson's disease. Teva Neuroscience was founded in 1997 and was located in Kansas City, MO | Health Technology |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | Health Technology |
Catalys Pacific LLC
Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Finance |
- Stock Market
- Insiders
- Jon Congleton
- Experience
